Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-AnalysisShixue Chen, Yi Hu, Jinliang Wang et al.|Frontiers in Oncology|2021Cited by 125
Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancerDanyang Sun, Junxun Ma, Jinliang Wang et al.|Cancer Immunology Immunotherapy|2019Cited by 45
<p>Development and Validation of a Nomogram Model to Predict Acute Kidney Disease After Nephrectomy in Patients with Renal Cell Carcinoma</p>Xiaoying Hu, Zhangsuo Liu, Dongwei Liu et al.|Cancer Management and Research|2020Cited by 11
Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical MutationsXuan Zheng, Xiaoyun Lu|ACS Pharmacology & Translational Science|2024Cited by 6